Skip to search.
 TSX Up 0.13% TSX Ventures Down 0.17%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
35.30 Down 0.44(1.23%) 3:59PM EST
|After Hours : 35.30 Down 0.01 (0.04%) 4:18PM EST
Add to Portfolio
Prev Close:35.74
Open:36.00
Bid:35.00 x 1000
Ask:N/A
1y Target Est:44.73
Beta:1.31
Earnings Date:May 4 - May 8 (Est.)
Day's Range:35.18 - 36.83
52wk Range:28.26 - 45.45
Volume:471,923
Avg Vol (3m):746,327
Market Cap:1.48B
P/E (ttm):84.05
EPS (ttm):0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 1.23%1.48B
BIIBUp 2.77%99.85B
TEVADown 0.09%48.14B

Key Statistics

Forward P/E (1 yr):37.16
P/S (ttm):3.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.51
Quarterly EPS Est (Mar-15) :0.13
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):2.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback